USE OF CYSTEINE PROTEASE-INHIBITORS FOR TREATING ILLNESSES

Details for Australian Patent Application No. 2002304785 (hide)

Owner ABBOTT GMBH AND CO. KG

Inventors MOELLER, Achim; LUBISCH, Wilfried; NEUHOF, Heinz

Pub. Number AU-A-2002304785

PCT Number PCT/EP02/03399

PCT Pub. Number WO2003/080182

Priority 101 14 762.7 26.03.01 DE

Filing date 26 March 2002

Wipo publication date 8 October 2003

International Classifications

A61P 011/00 Drugs for disorders of the respiratory system

A61K 031/166 - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 101 14 762.7 26.03.01 DE

13 November 2003 Application Open to Public Inspection

  Published as AU-A-2002304785

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002304786-SULFONATED POLYETHERKETONEKETONE

2002304784-PHARMACEUTICAL COMPOSITIONS